<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02632266</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00002292</org_study_id>
    <nct_id>NCT02632266</nct_id>
  </id_info>
  <brief_title>Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants</brief_title>
  <official_title>Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is for the researchers to examine the safety and efficacy of liquid&#xD;
      human milk fortifier (HMF) in moderately preterm infants compared to powdered human milk&#xD;
      fortifier.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomize, double-blinded study in preterm infants born between 28-34&#xD;
      weeks gestation admitted to the NICU at the University of Kansas Hospital. After obtaining&#xD;
      informed consent, babies will be randomized to either liquid or powdered HMF using opaque,&#xD;
      sealed envelopes with preassigned randomization. The feeding protocol as established in the&#xD;
      KU NICU will be followed, beginning with initiation of trophic feeds, and advancement of&#xD;
      enteral feeds depending on the gestational age and preceding illnesses. Once infants reach&#xD;
      80ml/kg/day of enteral feeds, human milk will be fortified to 22 kilocalories by adding&#xD;
      either liquid or powdered fortifier. The beginning of the study(Study day 1) will be defined&#xD;
      as reaching and tolerating 100ml/kg/day of 24 kilocalorie human milk fortified with either&#xD;
      liquid or powdered fortifier. Enteral feeds will be advanced per unit protocol until they&#xD;
      reach 150-160ml/kg/day and 110-120 kcal/kg/day. the volume of feeds will be adjusted based on&#xD;
      the documented weight to provide energy and protein requirements as recommended by the&#xD;
      ESPGHAN guidelines. Babies will be followed up until the time of NICU discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">May 2019</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative weight gain</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>Weight gain of baby during the course of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in weight</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>Weight gain of baby week-to-week, during the course of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Linear length</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>change in length week-to-week during the course of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Head growth</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>Change in head measurements week-to-week during the course of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutrition biomarkers</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>Measurements of a baby's Ca, P, Mg, Alkaline Phosphatase and Prealbumin will be taken</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance to enteral feeds</measure>
    <time_frame>Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier</time_frame>
    <description>number of significant residuals, number of times feeds were held, NEC</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Complication of Prematurity</condition>
  <arm_group>
    <arm_group_label>Powder HMF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once patient has reached 80ml/kg/day of enteral feedings, 1 pack of powder HMF will be added to 50 ml of human or donor breast milk, then increased to a maximum of 2 packs for 50 ml following the unit feeding advancement protocol and this will be continued up until 48 hours prior to discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liquid HMF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once patient has reached 80ml/kg/day of enteral feedings, researchers will add 1 packet (5 ml) of liquid HMF to 50 ml of human or donor breast milk, then increase to 2 packs to 50 ml following the unit feeding protocol and this will be continued up until 48 hours prior to discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Powder HMF</intervention_name>
    <description>powder human milk fortifier</description>
    <arm_group_label>Powder HMF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Liquid HMF</intervention_name>
    <description>Liquid human milk fortifier</description>
    <arm_group_label>Liquid HMF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inborn preterm infants born between 28 0/7 and 34 0/7 weeks gestation and fed either&#xD;
             mother's own milk or donor human milk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Newborn infants &lt;28 weeks and &gt;34 weeks gestation, those with life threatening&#xD;
             illness, congenital and chromosomal anomalies, gastrointestinal anomalies or&#xD;
             necrotizing enterocolitis and fed premature formula&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Weeks</minimum_age>
    <maximum_age>34 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vishal Pandey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics. 1998 Sep;102(3):E38.</citation>
    <PMID>9724686</PMID>
  </results_reference>
  <results_reference>
    <citation>Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990 Dec 22-29;336(8730):1519-23.</citation>
    <PMID>1979363</PMID>
  </results_reference>
  <results_reference>
    <citation>Greer FR, McCormick A. Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr. 1988 Jun;112(6):961-9. Erratum in: J Pediatr 1988 Dec;113(6):1118.</citation>
    <PMID>3373407</PMID>
  </results_reference>
  <results_reference>
    <citation>Cibulskis CC, Armbrecht ES. Association of metabolic acidosis with bovine milk-based human milk fortifiers. J Perinatol. 2015 Feb;35(2):115-9. doi: 10.1038/jp.2014.143. Epub 2014 Aug 7.</citation>
    <PMID>25102321</PMID>
  </results_reference>
  <results_reference>
    <citation>Thoene M, Hanson C, Lyden E, Dugick L, Ruybal L, Anderson-Berry A. Comparison of the effect of two human milk fortifiers on clinical outcomes in premature infants. Nutrients. 2014 Jan 3;6(1):261-75. doi: 10.3390/nu6010261.</citation>
    <PMID>24394538</PMID>
  </results_reference>
  <results_reference>
    <citation>Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domell√∂f M, Embleton ND, Fusch C, Genzel-Boroviczeny O, Goulet O, Kalhan SC, Kolacek S, Koletzko B, Lapillonne A, Mihatsch W, Moreno L, Neu J, Poindexter B, Puntis J, Putet G, Rigo J, Riskin A, Salle B, Sauer P, Shamir R, Szajewska H, Thureen P, Turck D, van Goudoever JB, Ziegler EE; ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91. doi: 10.1097/MPG.0b013e3181adaee0.</citation>
    <PMID>19881390</PMID>
  </results_reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2015</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prematurity</keyword>
  <keyword>growth</keyword>
  <keyword>nutrition</keyword>
  <keyword>human milk fortifier</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

